Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

China needs tougher enforcement of vaccine regulation: WHO

China must strengthen regulation of its market for vaccines, the World Health Organization (WHO) said on Monday, after a bust of an illegal black market drugs ring this month underscored the country’s regulatory weaknesses. Police have arrested more than 130 suspects over a scandal in which 310 million yuan ($48 million) of illegal vaccines was […]

Read More »

U.S. Alleges Novartis AG Hosted 80,000 ‘Sham’ Events to Wine and Dine Doctors

Novartis AG is under pressure from the U.S. Attorney’s office in Manhattan to provide information about 80,000 “sham” events.

Read More »

Bay Area’s XenoPort Snags Psoriasis and MS Deal Worth $490 Million+

Hyberabad, India-based Dr. Reddy’s Laboratories announced today that it had inked a licensing deal with Santa Clara, Calif.-based XenoPort worth more than $490 million.

Read More »

FDA Scorns Eagle Pharma’s Seven-Year Orphan Drug Exclusivity

March 28, 2016 By Alex Keown, Breaking News Staff   WOODCLIFF LAKE, N.J. – Shares of Eagle Pharmaceuticals EGRX)are down about 8 percent this morning after the U.S. Food and Drug Administration rejected the company’s request for seven years of orphan drug exclusivity in the U.S. for its blood cancer drug, Bendeka. The regulatory […]

Read More »

Pharma Engagement Strategy with IDNs – Embedding in Clinical Pathways

While every medical case is unique, payers and providers are attempting to standardize treatment since unnecessary variation is a major source of growing costs.

Read More »

U.S. spends $3 billion a year on unused cancer drugs

U.S. doctors and hospitals throw out almost $3 billion (roughly 2.7 billion euros) in unused cancer drugs each year because the medicines come in supersized single-use packages and excess medicine must be discarded for safety reasons, a recent paper suggests. Researchers focused on 20 expensive medicines that are given by injection or intravenous drip and […]

Read More »

Transforming The Sales and Marketing Model

The Clinical Specialist Model and the Service Rep Model are considered two of the most successful innovative approaches in S&M for pharmaceutical companies.

Read More »

Terumo Issued Warning Letter Over Destination Guiding Vascular Sheaths

The FDA sent a warning letter to Terumo Corp. over issues with the manufacturing and quality control of its Destination Guiding vascular sheaths.

Read More »

Seven Potential Blockbuster Drugs May Hit The Market This Year

The analysts at Thomson Reuters have consulted their crystal balls and come up with seven drugs coming out this year that will likely hit blockbuster status – defined as marking more than $1 billion annually.

Read More »

Despite Bad-Luck Streak, Gilead Clinches Deal for HQ Expansion

March 25, 2016By Alex Keown, Breaking News Staff   FOSTER CITY, Calif. – Although Gilead Sciences (GILD) is in the midst of a legal battle that could cost it about $3 billion, the Foster City-based company snapped up property in the San Francisco Bay area that could provide 800,000 square-feet of space in an […]

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

April 2019 Focus: Healthcare agency & network profiles, industry overview & awards, and more!


Ad Right Bottom